Q1 2016 13F Holders as of 3/31/2016
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
86.6M
-
Number of holders
-
26
-
Total 13F shares, excl. options
-
9.44M
-
Shares change
-
+9.44M
-
Total reported value, excl. options
-
$126M
-
Value change
-
+$126M
-
Number of buys
-
26
-
Price
-
$13.32
Significant Holders of Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share (SNDX) as of Q1 2016
26 filings reported holding SNDX - Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share as of Q1 2016.
Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share (SNDX) has 26 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9.44M shares
of 86.6M outstanding shares and own 10.91% of the company stock.
Largest 10 shareholders include MPM ASSET MANAGEMENT LLC (2.17M shares), FMR LLC (2.09M shares), WELLINGTON MANAGEMENT GROUP LLP (1.32M shares), ORBIMED ADVISORS LLC (757K shares), EcoR1 Capital, LLC (511K shares), JENNISON ASSOCIATES LLC (461K shares), BLACKROCK ADVISORS LLC (309K shares), TIVERTON ASSET MANAGEMENT LLC (289K shares), Redmile Group, LLC (263K shares), and Boxer Capital, LLC (234K shares).
This table shows the top 26 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.